Latest Ratios: P/E Ratio 744.7x · EV/EBITDA 15.3x · ROE 0.2%. (2000–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.5B | $2.1B | $2.1B | $1.7B | $2.3B | $8.7B | $5.3B | $3.5B | $2.5B | $1.9B | $1.2B |
| Enterprise Value | $1.5B | $2.1B | $2.1B | $1.8B | $2.6B | $8.8B | $5.3B | $3.5B | $2.6B | $2.1B | $1.4B |
| P/E Ratio → | 744.70 | 1022.57 | 164.89 | — | 420.17 | 111.38 | 162.19 | 57.15 | 65.85 | 61.39 | 130.38 |
| P/S Ratio | 1.27 | 1.77 | 1.85 | 1.48 | 1.79 | 7.64 | 5.88 | 3.91 | 3.15 | 2.62 | 1.80 |
| P/B Ratio | 1.24 | 1.70 | 1.66 | 1.43 | 2.05 | 7.54 | 5.43 | 4.15 | 3.65 | 3.63 | 2.90 |
| P/FCF | 17.27 | 24.17 | 13.61 | 12.19 | 135.78 | 42.65 | 40.08 | 42.11 | 50.09 | — | 66.57 |
| P/OCF | 11.79 | 16.50 | 10.97 | 9.39 | 29.75 | 37.32 | 28.25 | 24.20 | 23.89 | 75.60 | 26.07 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.78 | 1.86 | 1.61 | 2.01 | 7.81 | 5.93 | 3.89 | 3.24 | 2.87 | 2.09 |
| EV / EBITDA | 15.34 | 21.45 | 23.01 | 24.24 | 26.85 | 50.69 | 49.41 | 24.52 | 26.66 | 35.89 | 22.35 |
| EV / EBIT | 129.29 | 138.37 | 68.82 | — | — | 100.04 | 148.97 | 44.58 | 57.49 | 184.41 | 67.71 |
| EV / FCF | — | 24.26 | 13.70 | 13.23 | 152.58 | 43.59 | 40.40 | 41.91 | 51.46 | — | 77.21 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 42.9% | 42.9% | 42.3% | 43.6% | 45.4% | 49.0% | 46.3% | 48.7% | 47.3% | 45.0% | 45.3% |
| Operating Margin | 1.0% | 1.0% | 0.0% | -1.7% | -0.2% | 7.9% | 4.0% | 8.7% | 5.6% | 0.8% | 0.9% |
| Net Profit Margin | 0.2% | 0.2% | 1.1% | -1.8% | 0.4% | 6.9% | 3.6% | 6.8% | 4.8% | 2.9% | 0.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 0.2% | 0.2% | 1.0% | -1.8% | 0.5% | 7.4% | 3.6% | 8.0% | 6.3% | 4.3% | 0.1% |
| ROA | 0.1% | 0.1% | 0.6% | -0.9% | 0.3% | 3.9% | 2.1% | 5.3% | 3.7% | 2.2% | 0.1% |
| ROIC | 0.7% | 0.7% | 0.0% | -1.1% | -0.1% | 5.7% | 2.9% | 7.5% | 4.6% | 0.7% | 1.0% |
| ROCE | 0.8% | 0.8% | 0.0% | -1.1% | -0.2% | 6.4% | 2.8% | 8.3% | 5.4% | 0.8% | 1.1% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.17 | 0.17 | 0.31 | 0.52 | 0.55 | 0.47 | 0.55 | 0.13 | 0.20 | 0.41 | 0.59 |
| Debt / EBITDA | 2.08 | 2.08 | 4.25 | 8.06 | 6.37 | 3.10 | 4.93 | 0.78 | 1.41 | 3.67 | 3.92 |
| Net Debt / Equity | — | 0.01 | 0.01 | 0.12 | 0.25 | 0.17 | 0.04 | -0.02 | 0.10 | 0.34 | 0.46 |
| Net Debt / EBITDA | 0.08 | 0.08 | 0.15 | 1.92 | 2.96 | 1.10 | 0.40 | -0.12 | 0.71 | 3.10 | 3.08 |
| Debt / FCF | — | 0.09 | 0.09 | 1.05 | 16.81 | 0.95 | 0.32 | -0.20 | 1.38 | — | 10.64 |
| Interest Coverage | 3.90 | 3.90 | 6.66 | — | -17.87 | 3.95 | 16.94 | 13.50 | — | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.43 | 1.43 | 1.37 | 2.52 | 2.06 | 0.89 | 3.00 | 2.04 | 1.94 | 1.73 | 1.74 |
| Quick Ratio | 1.22 | 1.22 | 1.22 | 2.22 | 1.71 | 0.75 | 2.65 | 1.58 | 1.45 | 1.28 | 1.36 |
| Cash Ratio | 0.41 | 0.41 | 0.64 | 1.27 | 0.80 | 0.41 | 1.79 | 0.58 | 0.33 | 0.15 | 0.30 |
| Asset Turnover | — | 0.60 | 0.52 | 0.52 | 0.59 | 0.53 | 0.49 | 0.72 | 0.73 | 0.73 | 0.74 |
| Inventory Turnover | 6.71 | 6.71 | 7.23 | 5.88 | 4.79 | 4.81 | 4.97 | 4.26 | 4.11 | 4.10 | 5.47 |
| Days Sales Outstanding | — | 66.80 | 84.14 | 83.97 | 84.34 | 77.67 | 77.78 | 88.85 | 90.98 | 101.33 | 79.21 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 0.1% | 0.1% | 0.6% | — | 0.2% | 0.9% | 0.6% | 1.7% | 1.5% | 1.6% | 0.8% |
| FCF Yield | 5.8% | 4.1% | 7.3% | 8.2% | 0.7% | 2.3% | 2.5% | 2.4% | 2.0% | — | 1.5% |
| Buyback Yield | 5.2% | 3.7% | 0.0% | 0.0% | 2.3% | 0.2% | 1.0% | 0.0% | 0.0% | 0.0% | 0.3% |
| Total Shareholder Yield | 5.2% | 3.7% | 0.0% | 0.0% | 2.3% | 0.2% | 1.0% | 0.0% | 0.0% | 0.0% | 0.3% |
| Shares Outstanding | — | $46M | $46M | $45M | $46M | $48M | $44M | $43M | $41M | $39M | $37M |
Includes 30+ ratios · 26 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying OMCL stock.
Omnicell, Inc.'s current P/E ratio is 744.7x. The historical average is 68.9x. This places it at the 100th percentile of its historical range.
Omnicell, Inc.'s current EV/EBITDA is 15.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 24.9x.
Omnicell, Inc.'s return on equity (ROE) is 0.2%. The historical average is 5.0%.
Based on historical data, Omnicell, Inc. is trading at a P/E of 744.7x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Omnicell, Inc. has 42.9% gross margin and 1.0% operating margin.
Omnicell, Inc.'s Debt/EBITDA ratio is 2.1x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.
Key Metrics
Top Statement Risk
SBC dilution and margin volatility
Metrics are mathematically derived from official filings.
Margin Recovery Gains Traction
Gross margin expanded from 38.7% in 2024Q1 to 49.0% in 2026Q2, while operating margin swung from -7.6% to 10.4%, indicating a strong cyclical recovery. According to the latest quarterly data, net margin reached 7.8%.
The 1,030 basis point gross margin expansion likely reflects a favorable product mix shift toward higher-margin software and services, as well as cost discipline. Operating leverage is evident as SG&A grew only 8.6% versus 26.8% revenue growth, driving operating margin from negative to double digits. However, stock-based compensation of $12.2M in 2026Q2 represents roughly half of net income, suggesting reported margins may overstate cash profitability.
Returns Rebound from Cyclical Lows
ROIC improved from -1.1% in 2024Q1 to 2.1% in 2026Q2, and ROE rose from -1.3% to 1.9% over the same period. Based on reported figures, returns remain below pre-cyclical levels but are trending upward.
The improvement in ROIC and ROE is driven primarily by margin recovery rather than asset efficiency, as asset turnover has remained stable around 0.16. The low absolute returns reflect the company's asset-light model with significant goodwill, which depresses returns on invested capital. Investors should monitor whether returns can continue to climb as revenue growth sustains and margins hold.
Working Capital Cycle Lengthens
The cash conversion cycle extended from 133 days in 2024Q1 to 97 days in 2026Q2, driven by a reduction in DSO from 95 to 72 days. As reported in the quarterly data, DPO has remained relatively stable around 30 days.
The improvement in DSO indicates better receivables collection, but the overall CCC remains elevated due to high inventory days (56) and a relatively short payable period. This suggests Omnicell holds significant inventory, possibly to support hardware sales, and has limited supplier leverage. The working capital swings have been volatile, impacting quarterly cash flow, but the trend is toward greater efficiency.
Debt Reduction Strengthens Balance Sheet
Total debt fell from $615.6M in 2024Q1 to $188.5M in 2026Q2, reducing D/E from 0.52 to 0.15. According to the latest balance sheet data, interest coverage improved to 23.03x in 2026Q1, indicating comfortable debt service.
The 69% reduction in debt has materially de-risked the balance sheet, providing greater financial flexibility. D/EBITDA has also improved from 136.82x in 2024Q1 to 13.58x in 2026Q2, though the latter remains elevated due to low EBITDA. The improved interest coverage suggests that debt service is not a near-term concern, but investors should monitor EBITDA growth to ensure leverage metrics continue to normalize.
Liquidity Buffer Strengthens
The current ratio improved from 1.37 in 2024Q4 to 1.64 in 2026Q2, while cash increased to $292.2M. Based on the latest quarterly data, the quick ratio of 1.43 indicates adequate short-term coverage.
The strengthening liquidity position provides a cushion against operational shocks, especially given the volatility in working capital. The quick ratio, which excludes inventory, remains above 1.0, suggesting that even without selling inventory, Omnicell can cover near-term liabilities. This is particularly important given the company's hardware inventory requirements.
Misapplied P/E Distorts Value
The trailing P/E of 801.35 is misleading due to depressed earnings, while the forward P/E of 15.69 better reflects normalized earnings. As reported in the valuation data, EV/EBITDA of 16.50 is more meaningful for this asset-light model.
The trailing P/E is distorted by the cyclical trough in earnings, making it an unreliable indicator of value. Investors should focus on forward multiples or EV/EBITDA, which account for the company's debt and cash position. Additionally, the high stock-based compensation suggests that reported EPS may overstate economic earnings, so cash-flow-based multiples like P/FCF (18.58) may be more appropriate.